[1]
S. SURINI, “DEVELOPMENT OF TRANSDERMAL DOSAGE FORM USING COPROCESSED EXCIPIENTS OF XANTHAN GUM AND CROSS-LINKED AMYLOSE: IN VITRO AND IN VIVO STUDIES”, Int J App Pharm, vol. 12, no. 1, pp. 207-211, Mar. 2020.